Microgen reports FY pre-tax profit

Source: Microgen


  • Operating performance slightly ahead of market expectations
  • Adjusted operating margin* remains strong at 17.9%, ahead of the Board's stated target. All internal research and development costs are expensed as incurred with no capitalisation of development costs.
  • Profit before tax from Continuing Operations of £4.2 million (2006: loss of £10.0 million)
  • Revenue from Continuing Operations of £33.3 million (2006: £32.7 million)
  • Microgen Aptitude gaining significant momentum and market recognition
  • Strong balance sheet with cash of £18.1 million (2006: £15.3 million)
  • Fully diluted earnings per share 2.5p (2006: loss per share 10.3p). Adjusted diluted earnings per share 4.5p (2006: 3.0p)
  • Proposed dividend increase of 33% with final dividend of 1.4p per share making a total of 2.0p for the year (2006: 1.5p) reflecting the confidence of the Board

    Read the full statement here:Download the document now 158.9 kb (PDF File)
  • Comments: (0)